Immunologic and Molecular Pathways Modulated by Oral Isotretinoin: Evidence from Human Studies
Cells · 17.11.2026 · 15 (22) · 2095
DOI: 10.3390/cells15222095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 17.11.2026. Verfasst von Sofiia Khimuk und 3 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Oral isotretinoin is an established systemic treatment for moderate-to-severe acne vulgaris, with biological effects extending beyond sebaceous gland suppression to the regulation of inflammatory, immune, and molecular processes. However, human evidence regarding these effects remains fragmented across studies investigating different biomarkers and regulatory pathways. This systematic review aimed to synthesize the available human evidence on immunological and molecular changes associated with oral isotretinoin therapy.
Methods
A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. PubMed, Scopus, and Web of Science were systematically searched for eligible human studies published in English.
Results
Eleven studies collectively reporting 920 patients with acne vulgaris receiving oral isotretinoin and 279 healthy controls (1199 participants) met the eligibility criteria. The investigated outcomes encompassed hematological and systemic inflammatory indices, circulating cytokines and immune mediators, antimicrobial peptides, transcription factors, gene and protein expression, and transcriptomic alterations. Oral isotretinoin was associated with reductions in several systemic inflammatory indices, particularly NLR, SII, and SIRI, although findings for other hematological parameters were inconsistent. Treatment-associated changes were also observed in YKL-40, IL-8, IL-36, TWEAK, dermcidin, FoxO1, and p53/TP53, while transcriptomic analysis identified alterations in immune- and inflammation-related gene expression and pathways.
Conclusions
Available human evidence indicates that oral isotretinoin is associated with changes in systemic inflammatory activity, circulating immune mediators, and selected molecular pathways. However, substantial heterogeneity across studies and the moderate-to-high risk of bias limit firm mechanistic conclusions.
Zitieren
APA
Khimuk, S., Andrusiewicz, A., Lipskaya, K., & Nowicka, D. (2026). Immunologic and Molecular Pathways Modulated by Oral Isotretinoin: Evidence from Human Studies. Cells, 15(22), 2095. https://doi.org/10.3390/cells15222095
Vancouver
Khimuk S, Andrusiewicz A, Lipskaya K, Nowicka D. Immunologic and Molecular Pathways Modulated by Oral Isotretinoin: Evidence from Human Studies. Cells. 2026;15(22):2095. doi:10.3390/cells15222095
BibTeX
@article{Khimuk2026,
author = {Khimuk, Sofiia and Andrusiewicz, Anastazja and Lipskaya, Katsiaryna and Nowicka, Danuta},
title = {Immunologic and Molecular Pathways Modulated by Oral Isotretinoin: Evidence from Human Studies},
journal = {Cells},
year = {2026},
volume = {15},
number = {22},
pages = {2095},
doi = {10.3390/cells15222095}
}
EUVIMED